KIORA PHARMACEUTICALS, INC. Lease Obligation Incurred
KIORA PHARMACEUTICALS, INC. (KPRX) reported Lease Obligation Incurred of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-02.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2018-03-02
- KIORA PHARMACEUTICALS, INC. lease obligation incurred for the quarter ending 2017-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. lease obligation incurred for the quarter ending 2016-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. lease obligation incurred for the quarter ending 2015-12-31 was $0.00.
- KIORA PHARMACEUTICALS, INC. lease obligation incurred for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- KIORA PHARMACEUTICALS, INC. lease obligation incurred for fiscal 2016 was $31.58K.
- KIORA PHARMACEUTICALS, INC. lease obligation incurred for fiscal 2015 was $0.00.
| Period end | Lease Obligation Incurred 3 month | Lease Obligation Incurred 9 month | Lease Obligation Incurred 12 month |
|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $0.00 10-K · filed 2018-03-02 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-14 | ||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $31.58K 10-K · filed 2018-03-02 | |
| 2016-09-30 | $31.58K 10-Q · filed 2017-11-14 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $0.00 10-K · filed 2017-02-23 | |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |